NewcelX Ltd. Files 6-K with Purchase Agreements and Warrants
Ticker: NCEL · Form: 6-K · Filed: 2026-04-01T17:03:06-04:00
Sentiment: neutral
Topics: financing, securities-purchase-agreement, warrants
TL;DR
NewcelX files 6-K: signed purchase agreements and warrants on April 1, 2026. Financing news.
AI Summary
NewcelX Ltd. filed a Form 6-K on April 1, 2026, reporting a Securities Purchase Agreement dated April 1, 2026. The filing includes exhibits detailing the form of the Securities Purchase Agreement, a Common Warrant, and a Pre-Funded Warrant, along with a press release from the same date. The company is based in Zurich, Switzerland, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates NewcelX Ltd. is engaging in financing activities through the issuance of securities, which could impact its capital structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves new securities purchase agreements and warrants, which can introduce financial risks and dilution for existing shareholders.
Key Players & Entities
- NewcelX Ltd. (company) — Filer of the 6-K report
- April 1, 2026 (date) — Date of the Securities Purchase Agreement and press release
- 0001783036 (company) — CIK number for NewcelX Ltd.
- THE CIRCLE 6 8058 ZURICH Switzerland (location) — Mailing and Business Address for NewcelX Ltd.
FAQ
What is the primary purpose of the Form 6-K filing by NewcelX Ltd. on April 1, 2026?
The Form 6-K filing on April 1, 2026, primarily serves to report a Securities Purchase Agreement dated April 1, 2026, along with related warrant forms and a press release.
What specific documents are included as exhibits in this 6-K filing?
The exhibits include the Form of Securities Purchase Agreement, the Form of Common Warrant, and the Form of Pre-Funded Warrant, as well as a press release.
Where is NewcelX Ltd. located?
NewcelX Ltd. is located in Zurich, Switzerland, with its mailing and business address at THE CIRCLE 6 8058 ZURICH Switzerland.
What is the CIK number for NewcelX Ltd.?
The CIK number for NewcelX Ltd. is 0001783036.
What industry sector does NewcelX Ltd. operate in?
NewcelX Ltd. operates in the Pharmaceutical Preparations sector (SIC code 2834).
From the Filing
EDGAR Filing Documents for 0001213900-26-038619 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001213900-26-038619 Filing Date 2026-04-01 Accepted 2026-04-01 17:03:06 Documents 6 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 REPORT OF FOREIGN PRIVATE ISSUER ea0284552-6k_newcelx.htm 6-K 29069 2 FORM OF SECURITIES PURCHASE AGREEMENT DATED AS OF APRIL 1, 2026, BETWEEN THE COM ea028455201ex10-1.htm EX-10.1 235384 3 FORM OF COMMON WARRANT ea028455201ex10-2.htm EX-10.2 94693 4 FORM OF PRE-FUNDED WARRANT ea028455201ex10-3.htm EX-10.3 92269 5 PRESS RELEASE DATED APRIL 1, 2026 ea028455201ex99-1.htm EX-99.1 11145 6 GRAPHIC ea028455201_ex99-1img1.jpg GRAPHIC 14088 Complete submission text file 0001213900-26-038619.txt 483314 Mailing Address THE CIRCLE 6 8058 ZURICH Switzerland Business Address THE CIRCLE 6 8058 ZURICH Switzerland 41-41-618-80-00 NewcelX Ltd. (Filer) CIK : 0001783036 (see all company filings) EIN. : 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231 Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 26829282 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)